A citation-based method for searching scientific literature

Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli, Jessica Read, Peter Langmuir, Anderson J Ryan, Martin J Schlumberger. J Clin Oncol 2012
Times Cited: 849



Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, Fatima Rangwala, Bhumsuk Keam. J Clin Oncol 2018
Times Cited: 353




List of shared articles



Times cited

Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga, Alessandro Antonelli. Semin Cancer Biol 2022
22

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI.
Cristina Dalmiglio, Lucia Brilli, Michele Campanile, Cristina Ciuoli, Alessandra Cartocci, Maria Grazia Castagna. Cancers (Basel) 2022
1

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Lucy X Ma, Osvaldo Espin-Garcia, Philippe L Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K Krzyzanowska. Thyroid 2022
0

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.
Na Qu, Zongguang Hui, Zhixin Shen, Chengxia Kan, Ningning Hou, Xiaodong Sun, Fang Han. Front Endocrinol (Lausanne) 2022
0

Targeted therapy and drug resistance in thyroid cancer.
Yujie Zhang, Zhichao Xing, Tianyou Liu, Minghai Tang, Li Mi, Jingqiang Zhu, Wenshuang Wu, Tao Wei. Eur J Med Chem 2022
0

Peptide Receptor Radionuclide Therapy in Thyroid Cancer.
Sriram Gubbi, Christian A Koch, Joanna Klubo-Gwiezdzinska. Front Endocrinol (Lausanne) 2022
0

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects.
Ivana Puliafito, Francesca Esposito, Angela Prestifilippo, Stefania Marchisotta, Dorotea Sciacca, Maria Paola Vitale, Dario Giuffrida. Front Endocrinol (Lausanne) 2022
0

Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers.
Lingyu Li, Lin Cheng, Ri Sa, Xian Qiu, Libo Chen. Crit Rev Oncol Hematol 2022
1

American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
David C Shonka, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park, Nagashree Seetharamu, Sina Jasim, Amr H Abdelhamid Ahmed, Keith C Bible, Marcia S Brose,[...]. Head Neck 2022
1

Nutrition in Advanced Thyroid Cancer Patients.
Laura Agate, Elisa Minaldi, Alessio Basolo, Valentina Angeli, Roberta Jaccheri, Ferruccio Santini, Rossella Elisei. Nutrients 2022
0

Systemic Therapy in Thyroid Cancer.
Amit Kumar Agrawal, Vanita Noronha, Vijay Patil, Nandini Menon, Akhil Kapoor, Anuradha Chougule, Pratik Chandrani, Kumar Prabhash. Indian J Surg Oncol 2022
0

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
S Filetti, C Durante, D M Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2022
0

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer.
Francesca Ragusa, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Eugenia Balestri, Chiara Botrini, Armando Patrizio, Valeria Mazzi, Giovanni Guglielmi, Rudy Foddis,[...]. Int J Mol Sci 2022
0

The Role of the Kinase Inhibitors in Thyroid Cancers.
Francesca Cuomo, Claudio Giani, Gilda Cobellis. Pharmaceutics 2022
0

Proteinuria is a late-onset adverse event in patients treated with cabozantinib.
V Cappagli, D Moriconi, A G Bonadio, D Giannese, Gaetano La Manna, M Francesca Egidi, G Comai, G Vischini, V Bottici, R Elisei,[...]. J Endocrinol Invest 2021
6

New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
Matthew D Ringel. J Clin Endocrinol Metab 2021
6


Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
1

Clinical cancer genomic profiling.
Debyani Chakravarty, David B Solit. Nat Rev Genet 2021
20

Translational Utility of Liquid Biopsies in Thyroid Cancer Management.
Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
1